AbbVie: 8th week, trade up 19%
AbbVie gains 1.9% near record highs, with earnings due this very week
AbbVie: 8th week, trade up 19%
Our view last week
AbbVie shares bounce 2.6% after last week's pullback, but the push is already creaking: candle-body conviction is fading and buyer dominance is easing. This week's technical analysis still shows a solid picture - aligned moving averages, rising ADX - with the stock back near its all-time highs. The buy signal is in its seventh week, and the trade is up 16.89% since entry.
This week's summary
AbbVie shares close the week up 1.9% and stay within a whisker of their all-time highs, just 0.88% away. It's a level already tested 4 times over the past 10 weeks: a crowded wall, not open sky, which is why entry today only makes sense on a pullback. Earnings land this very week, on July 31, an active risk factor to watch. The buy signal is in its 8th week, and the trade is up 19.13% since entry.
IQS Phase
79
in tension
Signal Strength
59
medium
Sizing
STANDARD
Ranking
#44 / 124
US stocks in progress
Trade P&L %
+19.13%
from signal to today
Rank position
ranks 44th among the 124 Longs already running for US stocks in our ranking, with a signal strength of 59 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +0.92% · monthly +6.01%
ABBV belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content